+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Women's Digital Health Market by Type of Solutions, Therapeutic Application Areas, and Geography: Industry Trends and Global Forecasts, 2022-2035

  • PDF Icon

    Report

  • 294 Pages
  • April 2022
  • Region: Global
  • Roots Analysis
  • ID: 5571385

Over the past few years, there have been several advancements in the field of digital health market; this has led to an increase in the adoption of digital healthcare solutions. Specifically, the outbreak of COVID-19 pandemic prompted people all over the world to rely on digital medium to receive healthcare remotely. Females constitute 49.6% of the world’s total population and, in one of its reports, the US department of labor reported that females use digital health care solutions more than men. Further, in a recent survey, it was founded that the percentage of women adopting tele health platform rose from 13% to 38% post the outbreak of COVID-19. Currently, there are more than 100 marketed solutions focused on women’s digital health; these include applications, software and devices. Some of these solutions have also been approved by the USFDA for therapeutic applications in areas, such as reproductive health and menstrual health. It is worth noting that, NC° Birth Control, developed by Natural Cycles, was the first application to receive approval from US FDA in 2018; the application can be used as a method of contraception and helps in regularly tracking menstrual cycle. 



Several developers are actively engaged in the development of solutions related to women’s digital health. In fact, a number of start-ups focused on women’s digital health have been established in the last few years, indicating the growing interest in this sector. A variety of solutions, such as women’s health diagnostic devices, women’s health applications as well as digital services for women, primarily targeting reproductive health, menstrual health, pelvic floor care and fetal health, are being developed by digital women’s health solution providers. Owing to the fact that women’s digital health is a relatively niche field, extensive research and development is required in order to meet the existing unmet needs of women. Having said that, the domain has attracted significant attention from the investors and healthcare venture capitalists, which have invested close to USD 3 billion over the past few years, enabling the femtech business flourish. Given the increasing research efforts and active involvement of investors, we expect a variety of applications and devices focused on improving women’s health to be developed, enabling the women’s digital health market to witness steady growth over the coming years.


Scope of the Report


The “Women’s Digital Health Market by Type of Solutions (Applications / Software, Devices and Services), Therapeutic Application Areas (Fetal Health, General Wellness, Menstrual Cycle, Pelvic Care, Reproductive Health / Fertility, and Other Therapeutic Areas), and Geography (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa): Industry Trends and Global Forecasts, 2022-2035” report features an extensive study on the current market landscape, offering an informed opinion on the likely future potential of women’s digital health solution providers, over the next decade. The study underlines an in-depth analysis, highlighting the diverse capabilities of various industry stakeholders engaged in this field.


In addition to other elements, the report includes:

  • A detailed assessment of the overall market landscape of women’s digital health solution providers along with the information on their year of establishment, company size, location of headquarters, type of solution(s) offered (applications / software, devices and services). In addition to this, the chapter provides details on the type of solution(s) offered along with information on their current status of development, ratings, therapeutic application area, usage period with respect to pregnancy, purpose and end-users. 
  • Detailed profiles of key players engaged in the women’s digital health market (shortlisted on the basis of company size). Each profile features a brief overview of the company, its financial information (if available), details on the solution(s) offered, recent developments and an informed future outlook.A detailed analysis of the various funding and investments made since 2016, including venture capital financing, secondary offering, private placement, grant, debt financing and other equity in the companies focused on offering solutions for women’s digital health.
  • An analysis of the partnerships that have been established in this domain since 2015, covering commercialization agreements, distribution agreements, licensing and distribution agreements, product / technology integration agreements, product development agreements, service agreements, manufacturing agreements, R&D agreements, and product development and commercialization agreements.
  • An analysis of the start-ups / small players (established in the last ten years, with less than 50 employees) engaged in the women’s digital health market, featuring spider web representations based on several relevant parameters, such as number of solution(s) offered, therapeutic application areas, usage period with respect to pregnancy, details on funding (including funding amount, and evolution of investment activity) and partnership activity.
  • A detailed analysis of the global events attended by the participants, based on several relevant parameters, such as year of event, type of event platform, location of event, emerging focus areas, active organizers (in terms of number of events), active industry and non-industry participants, designation of participants, affiliated department of participant, active speakers (in terms of number of events). Additionally, the chapter highlights geographical mapping of the upcoming events.
  • A roadmap for the development of women’s digital health solutions, such as applications and devices considering various factors that impact pre-development, development and post-development process. It also highlights the current unmet needs in digital health solutions for women across different therapeutic application areas.



One of the key objectives of the report was to understand the primary growth drivers and estimate the potential opportunities for the women’s digital health market. We have provided an informed estimate of the evolution of women’s digital health market for the period 2022-2035. Our year-wise projections of the current and future opportunity have further been segmented across type of solution(s) (applications / software, devices and services offered / available), therapeutic application area (fetal health, general wellness, menstrual cycle, pelvic area, reproductive health / fertility and others) and key geographies (North America, Europe, Asia-Pacific, Latin America and Middle East and North Africa). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

The opinions and insights presented in the report were influenced by discussions held with several stakeholders in the industry.


The report features detailed transcripts of interviews held with the following individuals (in alphabetical order): 

  • Maryam Ziaei (Founder and Chief Executive Officer, iSONO Health)
  • Ann Garnier (Founder and Chief Executive Officer, Lisa Health)
  • Honny Hillegonda Kipnis Groen (Chief Marketing Officer, Illumigyn)


All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.


Key Questions Answered

  • Who are the leading industry players offering solutions for women’s digital health?
  • Which women’s digital health applications and devices have been approved by the FDA?
  • What kind of partnership models are commonly adopted by industry and non-industry stakeholders?
  • Who are the key investors active in the field of women’s digital health?
  • What is the focus of global events / conferences held for women’s digital health?
  • What is the roadmap for the development of women’s digital health solutions?
  • What are the various unmet needs across different therapeutic application areas in the current women’s digital health market?
  • How is the current and future opportunity related to women’s digital health likely to be distributed across key market segments?

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Digital Health
3.3. Women’s Digital Health
3.4. Importance of Women’s Digital Health
3.5. Challenges Related to Women’s Digital Health
3.6. Future Perspectives
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2 Women’s Digital Health: Product Pipeline
4.2.1 Analysis by Type of Solution
4.2.2 Analysis by Current Status of Development
4.2.3 Analysis of Women’s Digital Health Applications by Ratings
4.2.4 Analysis by Therapeutic Application Area
4.2.5 Analysis by Usage Period with respect to Pregnancy
4.2.6 Analysis by Purpose
4.2.7 Analysis by End-Users
4.2.8 Analysis by Therapeutic Application Area and Type of Solution
4.3 Women’s Digital Health: Developer Landscape
4.3.1 Analysis by Year of Establishment
4.3.2 Analysis by Company Size
4.3.3 Analysis by Region of Headquarters
4.3.4 Analysis by Company Size and Region of Headquarters
4.3.5 Analysis by Location of Headquarters
4.3.6 Leading Players: Analysis by Number of Solutions
4.3.7 Regional Landscape: Analysis by Type of Solution
5. WOMEN’S DIGITAL HEALTH DEVELOPERS IN NORTH AMERICA: COMPANY PROFILES
5.1. Chapter Overview
5.2. Garmin
5.2.1. Company Overview
5.2.2. Product / Service Portfolio
5.2.3. Women’s Digital Health Product / Service(s) Offered
5.2.4. Recent Developments and Future Outlook
5.3. Kindbody
5.3.1. Company Overview
5.3.2. Product / Service Portfolio
5.3.3. Women’s Digital Health Product / Service(s) Offered
5.3.4. Recent Developments and Future Outlook
5.4. LetsGetChecked
5.4.1. Company Overview
5.4.2. Product / Service Portfolio
5.4.3. Women’s Digital Health Product / Service(s) Offered
5.4.4. Recent Developments and Future Outlook
5.5. Maven Clinic
5.5.1. Company Overview
5.5.2. Product / Service Portfolio
5.5.3. Women’s Digital Health Product / Service(s) Offered
5.5.4. Recent Developments and Future Outlook
5.6. Ro
5.6.1. Company Overview
5.6.2. Product / Service Portfolio
5.6.3. Women’s Digital Health Product / Service(s) Offered
5.6.4. Recent Developments and Future Outlook
5.7. Willow Innovations
5.7.1. Company Overview
5.7.2. Product / Service Portfolio
5.7.3. Women’s Digital Health Product / Service(s) Offered
5.7.4. Recent Developments and Future Outlook
6. WOMEN’S DIGITAL HEALTH DEVELOPERS IN EUROPE, ASIA-PACIFIC AND MIDDLE EAST & NORTH AFRICA: COMPANY PROFILES
6.1. Chapter Overview
6.2. Flo Health
6.2.1. Company Overview
6.2.2. Product / Service Portfolio
6.2.3. Women’s Digital Health Product / Service(s) Offered
6.2.4. Recent Developments and Future Outlook
6.3. Hubble Connected
6.3.1. Company Overview
6.3.2. Product / Service Portfolio
6.3.3. Women’s Digital Health Product / Service(s) Offered
6.3.4. Recent Developments and Future Outlook
6.4. International Medical Center
6.4.1. Company Overview
6.4.2. Product / Service Portfolio
6.4.3. Women’s Digital Health Product / Service(s) Offered
6.4.4. Recent Developments and Future Outlook
7. FUNDING AND INVESTMENT ANALYSIS
7.1. Chapter Overview
7.2. Types of Funding
7.3. Women’s Digital Health: Funding and Investment Analysis
7.3.1. Analysis by Year, Type of Funding and Amount Invested
7.3.2. Analysis by Year of Investment
7.3.3. Analysis by Amount Invested
7.3.4. Analysis by Type of Funding
7.3.5. Analysis by Type of Funding and Amount Invested
7.3.6. Most Active Players: Analysis by Number of Funding Instances
7.3.7. Most Active Players: Analysis by Amount Raised
7.3.8. Key Investors: Analysis by Number of Instances
7.3.9. Analysis by Type of Solution
7.3.10. Analysis by Type of Solution and Amount Invested
7.3.11. Analysis by Therapeutic Application Area
7.3.12. Analysis by Geography
7.3.13. Analysis by Year, Therapeutic Application Area and Amount Invested
7.3.14. Summary of Investments
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2 Partnership Models
8.3. List of Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Product / Solution
8.3.4. Analysis by Type of Partner
8.3.5. Analysis by Year of Partnership and Type of Partner
8.3.6. Analysis by Type of Partnership and Product / Solution
8.3.7. Most Active Players: Analysis by Number of Partnerships
8.3.8. Leading Players: Analysis by Type of Partnership
8.3.9. Regional Analysis
8.3.10. Intercontinental and Intracontinental Agreements
9. START UP HEALTH INDEXING
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Benchmarking of Start-ups
9.3.1. Analysis by Type of Product / Solution
9.3.2. Analysis by Therapeutic Application Area
9.3.3. Analysis by Usage Period with respect to Pregnancy
9.3.4 Analysis by Partnership Activity
9.3.5. Analysis by Funding Activity
9.3.6. Analysis by Progression of Funding
9.3.7. Analysis by Type of Funding
9.3.8. Analysis by Location of Headquarters
9.3.9. Start-up Health Indexing: Publisher Perspective
10. GLOBAL EVENTS ANALYSIS
10.1. Chapter Overview
10.2. Scope and Methodology
10.3. Global Events related to Women’s Digital Health
10.3.1. Analysis by Year of Event
10.3.2. Analysis by Event Platform
10.3.3. Analysis by Type of Event
10.3.4. Analysis by Geography
10.3.5. Word Cloud: Evolutionary Trends in Event Agenda / Key Focus Areas
10.3.6. Most Active Event Organizers: Analysis by Number of Events
10.3.7. Most Active Participants: Analysis by Number of Events
10.3.8. Analysis by Seniority Level of Participants
10.3.9. Most Active Speakers: Analysis by Number of Events
10.3.10. Geographical Mapping of Upcoming Events
11. SWOT ANALYSIS
11.1. Chapter Overview
11.2. Women’s Digital Health: SWOT Analysis
11.2.1. Comparison of SWOT Factors
11.2.1.1. Strengths
11.2.1.2. Weaknesses
11.2.1.3. Opportunities
11.2.1.4. Threats
12. PRODUCT DEVELOPMENT AND SUCCESS ANALYSIS
12.1. Chapter Overview
12.2. Scope and Methodology
12.3. Roadmap for the Development of Women’s Digital Health Application
12.3.1. Application Development and Success Analysis: Pre-Development Parameters
12.3.2. Application Development and Success Analysis: Development Parameters
12.3.3. Application Development and Success Analysis: Post-Development Parameters
12.4. Roadmap for the Development of Women’s Digital Health Device
12.4.1. Device Development and Success Analysis: Pre-Development Parameters
12.4.2. Device Development and Success Analysis: Development Parameters
12.4.3. Device Development and Success Analysis: Post-Development Parameters
12.5. Women’s Digital Health: Unmet Needs
13. MARKET FORECAST AND OPPORTUNITY ANALYSIS
13.1. Chapter Overview
13.2. Forecast Methodology and Key Assumptions
13.3. Overall Women’s Digital Health Market, 2022-2035
13.3.1. Women’s Digital Health Market, 2022-2035: Distribution by Type of Solution
13.3.1.1. Women’s Digital Health Market for Applications / Software, 2022-2035
13.3.1.2. Women’s Digital Health Market for Devices, 2022-2035
13.3.1.3. Women’s Digital Health Market for Services Offered / Available, 2022-2035
13.4.1. Women’s Digital Health Market for Applications / Software, 2022-2035: Distribution by Therapeutic Application Area
13.4.1.1. Women’s Digital Health Applications / Software Market for Fetal Health, 2022-2035
13.4.1.2. Women’s Digital Health Applications / Software Market for General Wellness, 2022-2035
13.4.1.3. Women’s Digital Health Applications / Software Market for Menstrual Cycle, 2022-2035
13.4.1.4. Women’s Digital Health Applications / Software Market for Pelvic Care, 2022-2035
13.4.1.5. Women’s Digital Health Applications / Software Market for Reproductive Health / Fertility, 2022-2035
13.4.1.6. Women’s Digital Health Applications / Software Market for Others, 2022-2035
13.4.2. Women’s Digital Health Market for Applications / Software, 2022-2035: Distribution by Geography
13.4.2.1. Women’s Digital Health Applications / Software Market in North America, 2022-2035
13.4.2.2. Women’s Digital Health Applications / Software Market in Europe, 2022-2035
13.4.2.3. Women’s Digital Health Applications / Software Market in Asia-Pacific, 2022-2035
13.4.2.4. Women’s Digital Health Applications / Software Market in Latin America, 2022-2035
13.4.2.5. Women’s Digital Health Applications / Software Market in Middle East and North Africa, 2022-2035
13.4.2.6. Women’s Digital Health Applications / Software Market in Rest of the World, 2022-2035
13.5.1. Women’s Digital Health Market for Devices, 2022-2035: Distribution by Therapeutic Application Area
13.5.1.1. Women’s Digital Health Device Market for Fetal Health, 2022-2035
13.5.1.2. Women’s Digital Health Device Market for General Wellness, 2022-2035
13.5.1.3. Women’s Digital Health Device Market for Menstrual Cycle, 2022-2035
13.5.1.4. Women’s Digital Health Device Market for Pelvic Care, 2022-2035
13.5.1.5. Women’s Digital Health Device Market for Reproductive Health / Fertility, 2022-2035
13.5.1.6. Women’s Digital Health Device Market for Others, 2022-2035
13.5.2. Women’s Digital Health Market for Devices, 2022-2035: Distribution by Geography
13.5.2.1. Women’s Digital Health Device Market in North America, 2022-2035
13.5.2.2. Women’s Digital Health Device Market in Europe, 2022-2035
13.5.2.3. Women’s Digital Health Device Market in Asia-Pacific, 2022-2035
13.5.2.4. Women’s Digital Health Device Market in Latin America, 2022-2035
13.5.2.5. Women’s Digital Health Device Market in Middle East and North Africa, 2022-2035
13.5.2.6. Women’s Digital Health Device Market in Rest of the World, 2022-2035
14. ROLE OF DIGITALIZATION IN WOMEN’S LIFE
14.1. Chapter Overview
14.2. Evolution of Digital Solutions for Women during COVID-19 Pandemic
14.2.1. Learning New Skills
14.3. Opportunities in Professional and Personal Life
14.3.1. Small Scale Online Businesses
14.3.2. Demand for Online Financial Products
14.4. Existing Digital Gender Gap
14.4.1. Impact of AI on Digital Gender Gap
14.5. Skills Shortfall
14.6. Strengthening Ways for Digital Adoption among Women
15. DIGITAL TRENDS: RESHAPING THE FUTURE OF HEALTHCARE
15.1. Chapter Overview
15.2. Artificial Intelligence
15.2.1. Role of Artificial Intelligence in Healthcare
15.2.2. Digital Adoption: Companies employing Artificial Intelligence in Healthcare Solutions
15.3. Machine Learning
15.3.1. Role of Machine Learning in Healthcare
15.3.2. Digital Adoption: Companies employing Machine Learning in
15.4. Deep Learning
15.4.1. Role of Deep Learning in Healthcare
15.5. Metaverse
15.5.1. Role of Metaverse in Healthcare
15.6. Conclusion
16. CONCLUSION
17. EXECUTIVE INSIGHTS
17.1. Chapter Overview
17.2. iSONO Health
17.2.1. Company Snapshot
17.2.2. Interview Transcript: Maryam Ziaei, Founder and Chief Executive Officer
17.3. Lisa Health
17.3.1. Company Snapshot
17.3.2. Interview Transcript: Ann Garnier, Founder and Chief Executive Officer
17.4. Illumigyn
17.4.1. Company Snapshot
17.4.2. Interview Transcript: Honny Hillegonda Kipnis Groen, Chief Marketing Officer
18. APPENDIX 1: TABULATED DATA19. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

Companies Mentioned

  • 2048 Ventures
  • 4FO Ventures
  • 8VC
  • a thousand colibris  
  • Aavia
  • Advanced Maternity Innovations
  • AH Trust
  • Aindra Systems
  • Alife Health
  • Allara Health
  • Alpha Femtech
  • Alsace Business Angels
  • AltaIR Capital
  • Althea Group 
  • Altitude Ventures
  • Alumni Ventures
  • Amadeus Capital Partners
  • Amboy Street Ventures
  • Anastasia Kovba
  • Anchorless Bangladesh
  • Andera Partners
  • AngelList Venture
  • Anthem
  • AOA
  • Astute
  • Autonomous Open Innovation (AOI)
  • App Basic
  • Apricity
  • Arbor Health
  • ArlanWasHere Investments
  • Artesian
  • Ascension Ventures
  • ASPIVIX
  • Asset Management Ventures
  • Astinno
  • Athena
  • Atheneum 
  • Atlantic Therapeutics
  • AtlasV Global
  • Atomico
  • Ava 
  • Avaana Capital
  • Avestria Ventures
  • Awesome People Ventures
  • AXA
  • Baby2Body
  • Babyscripts
  • Backstage Capital
  • Balance
  • Balderton Capital
  • BBG Ventures
  • Beehive Holdings
  • Bellabeat
  • Bethnal Green Ventures
  • BGF
  • Bia Med
  • Blackbird Ventures
  • Bloomer Tech
  • Bloomlife
  • Bloomth
  • Blossom Capital
  • Blue Cross Blue Shield of Massachusetts
  • Blue Ox Healthcare Partners
  • BlueRun Ventures 
  • Bolt Ventures
  • Bonnier Ventures
  • Bonzun
  • Borski Fund
  • Braster
  • BrightCap Ventures
  • Brilliantly
  • btov Partners
  • B-wom
  • Cambridge Design Partnership
  • Cambridge Digital Health
  • Cambridge Femtech Society
  • Candlelit
  • Canopie
  • Capier Investments
  • Carbomed Medical Solutions
  • Care4Cute
  • CareSignal
  • Carrot
  • Casdin Capital
  • Cayaba Care
  • Charles River Ventures
  • Chiaroscuro Foundation
  • Chorus Health
  • Cigna Ventures
  • Claritas Health Ventures
  • Clementine
  • Clue
  • Collaborative Fund
  • Company Ventures
  • Conference Series
  • Connors Centre 
  • Coroflo
  • Cortado Ventures
  • Council For Trade and Investment Promotion (CTIP)
  • COYA Partners
  • Creative Destruction Lab
  • Crescent Ridge Partners
  • Development Bank of Wales
  • Digital Health Today
  • DigiTx Partners
  • Downing Ventures
  • Dragoneer Investment Group
  • Dream Incubator
  • drip. menstrual cycle and fertility tracking
  • Ease Healthcare
  • Efficient Capacity
  • EIT Health
  • ElaWoman
  • Elda Health
  • Eli Health
  • Elidah
  • EloCare
  • Elvie
  • Elysium Venture Capital
  • Embr
  • Emme
  • Endeavour Vision
  • Endodiag
  • Endometrix
  • Enterprise Ireland
  • Enzia Ventures
  • EQT Ventures
  • eQventure
  • European Commission
  • European Innovation Council and SMEs Executive Agency (EISMEA)
  • Evernow
  • Exandus
  • Faegre Drinker
  • Fairhaven Health
  • Femasys
  • Femcare - Reverse PCOS, Consult Doctor Online
  • Femcy
  • FEMM
  • FEMNA
  • Femometer
  • FemTech Analytics
  • Femtech Focus
  • FemTec Healthcare
  • FemX
  • Ferne
  • Fertility Focus
  • FetoLife
  • First Round Capital
  • FirstCheck Africa
  • FirstMark Capital
  • Fish & Richardson
  • Fizimed
  • Flare Capital Partners
  • Flint Capital
  • Flo Health
  • Flöka
  • Fondation pour l'Innovation Technologique (FIT)
  • Forerunner Ventures
  • Foresight Group
  • Fortunis Capital
  • Founder Institute
  • Founders Fund
  • Foview
  • Frame Fertility
  • Frost & Sullivan
  • Frøya
  • Fuel Ventures
  • Future Positive Capital
  • Gals Bio
  • Garmin
  • gBETA Medtech
  • Gedeon Richter
  • General Catalyst 
  • Gennev
  • Global Founders Capital
  • Glow
  • Google
  • Grand Central Tech
  • Greycroft
  • GSK NEXT
  • GV
  • Hackster
  • Halza
  • Hambrecht Ducera Growth Ventures
  • Harvard Business School Association of Northern California (HBSANC)
  • Harvard Medical School
  • Harvard University
  • HAX
  • Haxus
  • Health & Her
  • Health Enterprise Partners (HEP)
  • Health in Her HUE
  • HealthXL
  • HeraMED
  • Hikma Ventures
  • HITLAB
  • Hiventures
  • HLM Venture Partners
  • Horizon 2020
  • Hubble Connected
  • Hybrid4apps
  • iBreve
  • Icon Ventures
  • Illumigyn
  • Illumina Ventures
  • iMama
  • Impact Ventures UK
  • Information Technology Academia Collaboration (ITAC)
  • Inito
  • Inne
  • Innovate UK
  • Inova Health System
  • Insignia Ventures Partners
  • International Medical Center Apps
  • IPOPEMA Securities
  • iSono Health
  • Iterative Capital 
  • iXensor
  • January Ventures
  • Jennis
  • Johnson Venture Partners (JVP)
  • Kamet Ventures
  • kegg
  • Kheiron Medical Technologies
  • Khyria
  • Kindbody
  • Konna
  • Kormeli
  • LabQ International
  • Lactamo
  • LactApp
  • Lactation Lab
  • LAIA
  • Leap Fitness Group
  • Leerink Transformation Partners
  • Lemonaid Health
  • LetsGetChecked
  • Life Science Innovation Fund
  • LifeSense Group (LSG)
  • Linchpin Healthcare
  • Lisa Health
  • Livia
  • League of Innovators
  • LSP
  • Lucina Analytics
  • Luma Womb
  • Lux Capital
  • Mabel
  • Mae
  • Magnetic Ventures
  • Mahmee
  • Maki.vc
  • Mangrove Capital Partners
  • MassChallenge
  • Material Impact
  • Materna Medical
  • Maven Clinic
  • Maven Ventures
  • Maveron
  • Maya 
  • McKinsey
  • MEDITA
  • Medtech Women
  • MemorialCare Innovation Fund (MCIF)
  • Menopod
  • Merchavia
  • Meridian Street Capital
  • Meritech Capital Partners
  • Meta
  • Metronomic 
  • Microsoft
  • Midlands Engine Investment Fund (MEIF)
  • MiMARK
  • Miracare
  • Mirco Bettelini
  • Massachusetts Institute of Technology (MIT)
  • MMD
  • MobileODT
  • Modern Fertility 
  • Monkfish Equity
  • MooDoos Investments
  • Moonai
  • Modern Fertility
  • MUTU
  • My Ava
  • Nabta Health
  • National Cancer Institute (NCI)
  • National Education Association (NEA)
  • National Health Service (NHS)
  • National Institutes of Health (NIH)
  • National Science Foundation (NSF)
  • Natural Cycles
  • Naytal
  • Nest Collaborative
  • New England-Israel Business Council (NEIBC)
  • Nex Cubed
  • Nexus Venture Partners
  • NGP Capital
  • Niramai
  • Nordic Eye Venture Capital
  • Novartis Venture Fund
  • NursElet
  • Nuvo Group
  • Oak HC/FT 
  • Oath Care
  • OCON Healthcare
  • Octopus Ventures
  • Oky
  • Olive Tree Ventures
  • Oova
  • Optum Ventures
  • Oratel Diagnostics
  • OrbiMed Advisors
  • Ordinary Folk
  • Orreco
  • OSF Ventures
  • Oshihar Apps
  • Oula
  • Ovia Health
  • Ovira
  • Ovulai
  • Ovulation Calculator
  • Pachamama
  • Parentlane
  • Parian Global Management
  • Partum Health
  • Pepapp
  • Peramare Enterprises
  • Perceptive Advisors
  • PeriGen
  • Phenomenal Women's Health
  • pi Ventures
  • Plackal Tech 
  • Plug and Play Tech Centre
  • Polytech Ventures
  • Pomelo Care
  • Pontifax Venture Capital
  • PreemieWorld
  • PregnaScan
  • Prima-Temp
  • Prime Venture Partners
  • Privia Health
  • Proactive for her
  • Proov
  • Public Policy Projects (PPP)
  • pumpspotting
  • Punchbowl
  • Qiming Venture Partners
  • Qualcomm Life
  • Raiing Medical
  • Raydiant Oximetry
  • Renalis
  • Renovia
  • Rhia Ventures
  • Ro
  • Roche 
  • Royal Philips
  • RRE Ventures
  • Sagentia Innovation
  • Salem Partners
  • Santora Nakama
  • Scientific Federation
  • SD Venture
  • Seashore Solutions
  • Sequoia Capital
  • Sera Prognostics
  • Serena Ventures
  • Seroba Life Sciences
  • Sevenlogics
  • Shareholder Value Management
  • She Loves Tech
  • SOSV
  • Spring Mountain Capital
  • Springboard Enterprises
  • Srirakshaa Healthcare
  • Starting Line
  • StartUp Health
  • State of Maine
  • SteadySense
  • SteelSky Ventures
  • Storka
  • Summit Reinsurance Services
  • SVC
  • Swiss Healthcare Startups (SHS)
  • Syrona Health
  • Tamtris Web Services
  • Target Global
  • Tech Up For Women
  • Tech4Eva
  • Techammer
  • Techstars
  • Tempdrop
  • Texas HALO Fund
  • The Body Literacy Collective
  • The Female Health Hub
  • International Technology Law Association (ITechLaw)
  • The Lily Project
  • The Pelvic Expert
  • Royal Society
  • Royal Society of Medicine 
  • Yozma
  • Think Bigger Capital
  • Tia
  • Tiger Global Management
  • Titan Capital  
  • Tooly Tech
  • TruDiary
  • True Ventures
  • Tutorify
  • U.S. Venture Partners
  • Ubicom Holdings
  • Uncork Capital
  • Union Square Ventures
  • United Nations University International Institute for Global Health (UNU-IIGH)
  • UnityPoint Health Ventures
  • University Hospitals
  • Uvi Health
  • VCapital 
  • Vectr Ventures
  • Veera Health 
  • Velmio
  • Venture Kick
  • Victorum Capital Club
  • Vivant
  • VNV Global
  • Vulvy
  • Wachanga
  • Walking Ventures
  • Watkins-Conti Products
  • Wavemaker 360
  • Western Development Commission
  • Wildflower Health
  • Willow
  • Women in Technology International WITI
  • Women In Bio
  • Women in Data
  • Women of Wearables (WoW)
  • Women's Health Connecticut  
  • WomenUP
  • Woom
  • Xpectives.Health
  • Y Combinator
  • Yesmom
  • Ysios Capital
  • Zaya
  • Zero Mothers Die
  • Zoie Health

Methodology

 

 

Loading
LOADING...